Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S5.57
P/E—
Fwd P/E16.50
PEG1.28
52W— – —
RSI—
Target$246.44 (+12.9%)
Beta0.77
Div1.09%
Loading chart…
RSI ()
Loading patterns…
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 42
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
8Bullish
4Bearish
0Neutral
Key Signals 2
▲ Double Bottom
Major reversal
2026-06-26 · $199.42
Two lows ~$181.94 — bullish reversal confirmed
Learn more →
▲ Double Bottom
Major reversal
2026-08-04 · $221.79
Two lows ~$186.92 — bullish reversal confirmed
Learn more →
Momentum Signals 10
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ Bull Flag
▲ MACD Bullish Crossover
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$246.44
+12.9% upside
Low $175
—
High $320
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
61.62%Last 12 Months
Operating Margin
30.86%Last 12 Months
Return on Equity
24.27%Last 12 Months
Revenue Growth
8.60%Year over Year
Free Cash Flow
939.25MLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
12.54Most Recent Quarter
Current Ratio
3.10Most Recent Quarter
Cash
1.47BMost Recent Quarter
Total Debt
825.92MMost Recent Quarter
Net Debt
—Most Recent Quarter
How RMD Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 31.49B |
| Enterprise Value | 30.84B |
| Trailing P/E | 21.05 |
| Forward P/E | 16.50 |
| PEG Ratio (5yr) | 1.28 |
| Price/Sales (ttm) | 5.57 |
| Price/Book (mrq) | 4.78 |
| EV/Revenue | 5.46 |
| EV/EBITDA | 14.72 |
Share Statistics
| Avg Vol (3m) | 1.50M |
| Shares Outstanding | 144.25M |
| Float | 143.36M |
| % Held by Insiders | 0.50% |
| % Held by Institutions | 71.27% |
| Short Ratio | 8.34 |
| Short % of Float | 10.45% |
Profitability
| Gross Margin | 61.62% |
| Operating Margin (ttm) | 30.86% |
| Profit Margin | 26.95% |
| Return on Assets (ttm) | 14.00% |
| Return on Equity (ttm) | 24.27% |
Income Statement
| Revenue (ttm) | 5.65B |
| Revenue Growth (yoy) | 8.60% |
| Gross Profit (ttm) | 3.48B |
| EBITDA | 2.10B |
| Net Income (ttm) | 1.52B |
| Diluted EPS (ttm) | 10.37 |
| EPS Growth (yoy) | 2.40% |
Balance Sheet
| Total Cash (mrq) | 1.47B |
| Total Debt (mrq) | 825.92M |
| Debt / Equity (mrq) | 12.54 |
| Current Ratio (mrq) | 3.10 |
| Book Value / Share | 45.66 |
| Operating CF (ttm) | 1.81B |
| Free Cash Flow (ttm) | 939.25M |
Trading & Dividends
| Beta (5Y) | 0.77 |
| 50-Day MA | 216.62 |
| 200-Day MA | 228.02 |
| Fwd Dividend Yield | 1.20% |
| Payout Ratio | 23.01% |
Income
Dividend Yield
1.09%Last 12 Months
Annual Rate
2.64Forward
Payout Ratio
23.01%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 23.01%
Monthly Dividends
Ownership Breakdown
Institutional 71.27%
Insider 0.50%
Public 28.2%
Short Interest
10.45% of float
High
Institutional 13F Holdings
Famous investors who disclosed a position in RMD in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|